Twist Bioscience Corporation Common Stock TWST
Analyst Ratings
- Consensus
- Moderate Buy — 7 Buy · 3 Hold · 1 Sell (11 analysts)
- Avg. Price Target
- $135.91 (+14.8% upside)
Key Stats
- Today's Range
- $109.97 – $119.81
- 50-Day Range
- $93.68 – $219.71
- 52-Week Range
- $23.30 – $219.71
- Volume
- 1.21 million shs
- Average Volume
- 2.50 million shs
- Market Cap
- $7.64 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.08%
- Days to Cover
- 1.00
About Twist Bioscience Corporation Common Stock
Twist Bioscience Corp provides customizable solutions across the biological continuum, helping customers read, write and innovate in biology. The core of its business is a proprietary platform that allows it to manufacture synthetic DNA by writing DNA on a silicon chip. The company operates as one reportable and operating segment, through which it develops, manufactures and sells DNA Synthesis and Protein Solutions and NGS Applications products and services. It has presence in Americas, EMEA, and APAC. Majority of revenue comes from Americas. Its products are Genes, Oligo Pools, NGS, Variant Libraries, Synthetic Controls, Antibody Discovery, and VDR Solutions.
Related Stocks
Compare head-to-head: TWST vs AMGN·TWST vs MRNA·TWST vs RGEN·TWST vs HALO
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
